T45.1X5D - Adverse effect of antineoplastic and immunosup drugs, subs
The ICD 10 Code for Adverse effect of antineoplastic and immunosup drugs, subs is listed as T45.1X5D.
Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
| ICD 10 CM Field | Value |
|---|---|
| Diagnosis Code: | T45.1X5D
|
| Description: | Adverse effect of antineoplastic and immunosup drugs, subs |
| Diagnostic Related Groups
(MS-DRG v30.0) |
949 - Aftercare W Cc/mcc
950 - Aftercare W/o Cc/mcc |
| Chapter | Injury, poisoning and certain other consequences of external causes (S00-T88) |
| Block | Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) |
| Parent | T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs |
| ICD-9-CM Diagnosis Codes General Equivalence Mappings (GEMS): | |
| ICD 9 Dx Code: | V58.89 - Other specified aftercare (approximate) |
| ICD-10-CM Siblings (same level / similar specificity) of T45.1X5D: | |
| T45.1X5A - Adverse effect of antineoplastic and immunosup drugs, init | |
| T45.1X5S - Adverse effect of antineopl and immunosup drugs, sequela | |